Understanding how to improve treatment outcomes for Chagas disease
Treatment outcome requirements for disease prevention in Chagas disease
This study is looking at how starting treatment sooner or later for Chagas disease in dogs can help them get better and protect their hearts, and the results could help us understand how to treat the disease in people too.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-10780477 on NIH RePORTER |
What this research studies
This research investigates the effects of early versus delayed treatment for Chagas disease, caused by the parasite Trypanosoma cruzi. By studying infected dogs in Texas, the project aims to determine how quickly treatment can improve health outcomes and reduce heart damage. The approach includes advanced testing methods to measure treatment success through blood samples and clinical assessments. The findings could provide valuable insights into managing Chagas disease in humans.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been recently infected with Trypanosoma cruzi or are at high risk of infection.
Not a fit: Patients who have chronic Chagas disease with significant heart damage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols that enhance recovery and reduce complications from Chagas disease.
How similar studies have performed: Previous research has shown promising results in treating Chagas disease with early intervention, suggesting that this approach could be effective.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Tarleton, Rick L — University of Georgia
- Study coordinator: Tarleton, Rick L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.